Defining the screening population. Children and adolescents identified by screening include those with undiagnosed monogenic dyslipidemia, undiagnosed secondary dyslipidemia, and idiopathic (polygenic or risk factor–driven) dyslipidemia. Children and adolescents with previously known monogenic or secondary dyslipidemia would be specifically evaluated for these indications and are not included in the screening pool for the general population.